Peg IFNα-2a in polycythemia vera (PV).: Results of a phase 2 study by the French "PV-NORD" group.

被引：0
|
作者：
Kiladjian, Jean-Jacques
Cassinat, Bruno
Turlure, Pascal
Cambier, Nathalie
Bellucci, Sylvia
Roussel, Murielle
Grange, Marie-Jose
Grandchamp, Bernard
Rain, Jean-Didier
Chomienne, Christine
Fenaux, Pierre
机构：
[1] Univ Paris 13, Hop Avicenne, Bobigny, France
[2] Hop St Louis, Paris, France
[3] CHU, Limoges, France
[4] CHRU, Lille, France
[5] Hop Lariboisiere, Paris, France
[6] Hop Bichat, F-75877 Paris, France
[7] Hop Bichat, INSERM, U656, F-75877 Paris, France
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2679
引用
收藏
页码：757A / 757A
页数：1
相关论文
共 50 条
  • [1] PVN1:: A phase 2 study of pegylated interferon-α2a in polycythemia vera (PV) by the "PV-Nord" group.: Preliminary report of efficacy and safety.
    Kiladjian, JJ
    Cassinat, B
    Turlure, P
    Bellucci, S
    Cambier, N
    Roussel, M
    Grange, MJ
    Rain, JD
    Chomienne, C
    Fenaux, P
    [J]. BLOOD, 2005, 106 (11) : 315B - 315B
  • [2] PEGYLATED INTERFERON-α-2A INDUCES COMPLETE HEMATOLOGICAL AND MOLECULAR RESPONSES WITH LOW TOXICITY IN POLYCYTHEMIA VERA: RESULTS OF THE PV-NORD PVN1 STUDY
    Kiladjian, J. J.
    Cassinat, B.
    Turlure, P.
    Cambier, N.
    Roussel, M.
    Bellucci, S.
    Chevret, S.
    Grandchamp, B.
    Chomienne, C.
    Fenaux, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 180 - 180
  • [3] Pegylated interferon-alfa-2a (PEG-IFN-α-2A; PEGASYSTM) for essential thrombocythemia (ET) and polycythemia vera (PV):: An update of an ongoing phase II study
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2007, 110 (11) : 1036A - 1037A
  • [4] Treatment with pegylated Interferon-Atfa-2A (PEG-IFN-Aα-2A; PEGASYS™) for patients with essential thrombocythemia (ET) and polycythemia vera (PV).
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Giles, Francis
    Cortes, Jorge
    Richie, Mary Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2006, 108 (11) : 307B - 307B
  • [5] Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial
    Turlure, Pascal
    Cambier, Nathalie
    Roussel, Murielle
    Bellucci, Sylvia
    Zini, Jean-Marc
    Rain, Jean-Didier
    Rousselot, Philippe
    Vainchenker, William
    Abdelkader, Lina
    Ghomari, Kamel
    Dutel, Jean-Luc
    Chait, Yasmine
    Chevret, Sylvie
    Chomienne, Christine
    Cassinat, Bruno
    Kiladjian, Jean-Jacques
    [J]. BLOOD, 2011, 118 (21) : 129 - 130
  • [6] Can Peg-Interferon (IFN) α-2a Eradicate JAK2V617F-Positive Bone Marrow Progenitors in Polycythemia Vera (PV)?
    Kiladjian, Jean-Jacques
    Dupont, Sabrina
    Cassinat, Bruno
    Masse, Aline
    Vainchenker, William
    Chomienne, Christine
    Delhommeau, Francois
    Fenaux, Pierre
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [7] Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
    Quintas-Cardania, Alfonso
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [8] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [9] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Lucia Masarova
    C. Cameron Yin
    Jorge E. Cortes
    Marina Konopleva
    Gautam Borthakur
    Kate J. Newberry
    Hagop M. Kantarjian
    Carlos E. Bueso-Ramos
    Srdan Verstovsek
    [J]. Experimental Hematology & Oncology, 6
  • [10] Dynamics of Mutant Alleles in Patients with Advanced Essential Thrombocythernia (ET) or Polycythemia (PV) During Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; Pegasys) Therapy
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Levine, Ross L.
    Manshouri, Taghi
    Roupie, Anne-Laure
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2011, 118 (21) : 130 - 130
12345